Treating refractory scleritis with infliximab

被引:0
作者
Seong Joon Ahn
Joo Youn Oh
Mee Kum Kim
Won Ryang Wee
机构
[1] Seoul National University College of Medicine,Department of Ophthalmology
[2] Seoul National University Hospital Clinical Research Institute,Seoul Artificial Eye Center
[3] Seoul National University College of Medicine,Department of Ophthalmology
来源
Japanese Journal of Ophthalmology | 2009年 / 53卷
关键词
infliximab; scleritis; tumor necrosis factor α;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:286 / 287
页数:1
相关论文
共 15 条
[1]  
Mychalova K.(2008)Biologic agents in the management of inflammatory eye diseases Curr Allergy Asthma Rep 8 339-447
[2]  
Lim L.(2007)Infliximab therapy for the treatment of refractory ocular inflammatory disease Arch Ophthalmol 125 895-900
[3]  
Sobrin L.(2006)Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation Ophthalmology 113 2317-2323
[4]  
Kim E.C.(2001)Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease Arthritis Rheum 45 252-257
[5]  
Christen W.(undefined)undefined undefined undefined undefined-undefined
[6]  
Papadaki T.(undefined)undefined undefined undefined undefined-undefined
[7]  
Letko E.(undefined)undefined undefined undefined undefined-undefined
[8]  
Foster C.S.(undefined)undefined undefined undefined undefined-undefined
[9]  
Galor A.(undefined)undefined undefined undefined undefined-undefined
[10]  
Perez V.L.(undefined)undefined undefined undefined undefined-undefined